As head of quality within a pharmaceutical company, I lead a team of quality specialists who oversee the end-to-end manufacturing process to ensure the 12bn tablets that are produced on an annual basis are in safe, compliant and in good quality. Within this role, we often think about truly end-to-end, from incoming goods, to tier 1/2 suppliers to our manufacturing sites, to product release for delivery in market and it helps us all connect to why we do it – for the patient.